Pulmonary Disease Doctors in Norwich, CT Accepting Medicare

8 Pulmonary Disease doctors found. Showing 1 - 8

Ankit Gupta, Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 330 Washington St Ste 430, Norwich, CT 06360 Phone: 860-886-1862    Fax: 860-886-2046

Dr. Jose Angelo Araullo De Dios, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 79 Wawecus St Ste 103, Norwich, CT 06360 Phone: 860-886-1862    Fax: 860-886-2046

Donna Marie Romito, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 79 Wawecus St Ste 103, Norwich, CT 06360 Phone: 860-886-1862    Fax: 860-886-2046

Dr. Atul Vijay Palkar, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 79 Wawecus St Ste 103, Norwich, CT 06360 Phone: 860-886-1862    Fax: 860-886-2046

Steven L Powell, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 330 Washington St, Ste 430, Norwich, CT 06360 Phone: 860-886-1862    Fax: 860-886-2046

Setu K Vora, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 12 Case St Ste 204, Norwich, CT 06360 Phone: 860-319-0470    Fax: 860-319-0398

Thinesh Dahanayake, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 79 Wawecus St Ste 103, Norwich, CT 06360 Phone: 860-886-1862    Fax: 860-886-2046

Dr. Resham Singh Pawar, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 79 Wawecus St Ste 103, Norwich, CT 06360 Phone: 860-886-1862    Fax: 860-886-2046

News Archive

ALS TDI and Oxford BioMedica extend collaboration to develop gene therapies for Lou Gehrig's disease

The ALS Therapy Development Institute and Oxford BioMedica announced today the extension of their collaboration following successful completion of the first phase. The extended collaboration, which is funded by the Muscular Dystrophy Association, aims to advance the development of Oxford BioMedica's preclinical gene therapy candidate, MoNuDin®, and to evaluate other gene-based strategies for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

First Edition: September 2, 2010

Today's headlines include reports about a new study examining the impact of the health overhaul on the small business workforce.

Victims of mobbing show behavioral and social inhibition; less skilled to face environmental challenges

A study by Naples investigators published in the current issue of Psychotherapy and Psychosomatics reports on what happens in the axis which controls the secretion of cortisol in victims of mobbing.

MRI and PET techniques can help monitor response of bone metastases to treatment

Imaging technologies are very useful in evaluating a patient's response to cancer treatment, and this can be done quite effectively for most tumors using RECIST, Response Evaluation Criteria in Solid Tumors.

Read more Medical News

› Verified 7 days ago